The Reduction in Medical and Care Costs for Diseases Associated with Being Bedridden in Rural Residents in Japan

Author(s)

Shoji A1, Kudo KI2, Murashita K2, Nakaji S2, Igarashi A3
1Healthcare Consulting Inc., Bunkyo-ku, 13, Japan, 2Hirosaki University, Hirosaki, Aomori, Japan, 3Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan

OBJECTIVES: We previously showed that the Center for Healthy Aging Program (CHAP) in a Japanese rural area, Hirosaki, is associated with the reduction of cardiovascular-disease-related costs. This study aims to assess the effect of the CHAP on the medical and care costs for diseases related to being bedridden.

METHODS: We compared the all-cause medical and care costs in patients diagnosed as dementia, stroke, or a fracture in the period from 1st July 2015 to 30th June 2019 (follow-up) using the claims data of residents in Hirosaki between three groups, identified by the participation of checkups during a year before the follow-up period (baseline): CHAP participants (CHAP group), residents who received an annual standard health checkup (SHC) group, and everyone else (no checkup group). We used a multivariate hurdle model considering age, sex, care level, and Charlson Comorbidity Index to adjust the difference in baseline characteristics.

RESULTS: Of 42,819 eligible residents, the numbers of those in the CHAP, SHC, and no checkup groups were 384 (0.9%), 9,805 (22.9%), and 32,630 (76.2%), respectively. The all-cause medical costs in the follow-up period were lowest in the CHAP group for all three diseases. In patients with a fracture, both all-cause care costs in the follow-up period and in the year before the follow-up end were lower in the CHAP group than in the no checkup group (risk ratio [RR] = 0.097, p = 0.022 and RR = 0.091, p = 0.018, respectively), but in patients with dementia, the former were not different while the latter were lower in the CHAP group (RR = 0.365, p = 0.233 and RR = 0.086, p < 0.001, respectively).

CONCLUSIONS: We observed the high reduction of care costs for patients with bedridden-associated diseases in the CHAP group, especially in the last year of the follow-up, suggesting the long-term effect of the CHAP.

Conference/Value in Health Info

2024-05, ISPOR 2024, Atlanta, GA, USA

Value in Health, Volume 27, Issue 6, S1 (June 2024)

Code

EE427

Topic

Economic Evaluation, Epidemiology & Public Health, Study Approaches

Topic Subcategory

Prospective Observational Studies, Public Health

Disease

Cardiovascular Disorders (including MI, Stroke, Circulatory), Musculoskeletal Disorders (Arthritis, Bone Disorders, Osteoporosis, Other Musculoskeletal), Neurological Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×